BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50639787 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 5-hydroxytryptamine receptor 2A Homo sapiens >8800 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639788 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc-3c(Cc4ccccc-34)c2)CC1 InChI=1S/C29H32FN3O2/c1-35-28-9-5-4-8-27(28)33-16-14-32(15-17-33)20-24(30)12-13-31-29(34)22-10-11-26-23(19-22)18-21-6-2-3-7-25(21)26/h2-11,19,24H,12-18,20H2,1H3,(H,31,34) QULJKIQETSQZKV-UHFFFAOYSA-N 50343786 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide::CHEMBL1774536 5-hydroxytryptamine receptor 2A Homo sapiens >10000 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343786&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248256 131346722 CHEMBL1774536 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639789 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(cc2)-c2ccccn2)CC1 InChI=1S/C27H31FN4O2/c1-34-26-8-3-2-7-25(26)32-18-16-31(17-19-32)20-23(28)13-15-30-27(33)22-11-9-21(10-12-22)24-6-4-5-14-29-24/h2-12,14,23H,13,15-20H2,1H3,(H,30,33) DXTFDOIEUMNMMV-UHFFFAOYSA-N 50343787 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-6-phenylnicotinamide::CHEMBL1774383 D(2) dopamine receptor Homo sapiens 390 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343787&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248158 131346723 CHEMBL1774383 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639790 FC(CCNC(=O)c1ccc(cc1)-c1ccccn1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C26H27Cl2FN4O/c27-22-4-3-6-24(25(22)28)33-16-14-32(15-17-33)18-21(29)11-13-31-26(34)20-9-7-19(8-10-20)23-5-1-2-12-30-23/h1-10,12,21H,11,13-18H2,(H,31,34) DUYVMDDLFWXUHZ-UHFFFAOYSA-N 50343788 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-6-phenylnicotinamide::CHEMBL1774384 D(2) dopamine receptor Homo sapiens 378 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343788&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248159 131346724 CHEMBL1774384 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639791 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C24H28FN3O3/c1-30-22-9-5-3-7-20(22)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-4-8-21(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) VGOPWFPTLSPLJJ-UHFFFAOYSA-N 50343789 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzofuran-2-carboxamide::CHEMBL1774385 D(2) dopamine receptor Homo sapiens 329 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343789&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248208 131346725 CHEMBL1774385 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639792 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 D(2) dopamine receptor Homo sapiens 14600 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639793 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H30FN3O4/c1-31-20-7-8-22-18(15-20)16-24(33-22)25(30)27-10-9-19(26)17-28-11-13-29(14-12-28)21-5-3-4-6-23(21)32-2/h3-8,15-16,19H,9-14,17H2,1-2H3,(H,27,30) CSQTYZHHBNDDMS-UHFFFAOYSA-N 50343790 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774532 D(2) dopamine receptor Homo sapiens 274 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343790&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248210 131346726 CHEMBL1774532 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639794 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H26Cl2FN3O3/c1-32-18-5-6-21-16(13-18)14-22(33-21)24(31)28-8-7-17(27)15-29-9-11-30(12-10-29)20-4-2-3-19(25)23(20)26/h2-6,13-14,17H,7-12,15H2,1H3,(H,28,31) TXDNMFSXILPGFK-UHFFFAOYSA-N 50343791 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774533 D(2) dopamine receptor Homo sapiens 279 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343791&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248211 131346727 CHEMBL1774533 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639795 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C24H29FN4O2/c1-31-23-9-5-4-8-22(23)29-14-12-28(13-15-29)17-19(25)10-11-26-24(30)21-16-18-6-2-3-7-20(18)27-21/h2-9,16,19,27H,10-15,17H2,1H3,(H,26,30) JLMZACVBNICYMZ-UHFFFAOYSA-N 50343792 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide::CHEMBL1774534 D(2) dopamine receptor Homo sapiens 421 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343792&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248212 131346728 CHEMBL1774534 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639796 FC(CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H25Cl2FN4O/c24-18-5-3-7-21(22(18)25)30-12-10-29(11-13-30)15-17(26)8-9-27-23(31)20-14-16-4-1-2-6-19(16)28-20/h1-7,14,17,28H,8-13,15H2,(H,27,31) VIHBCLOGDPFGGP-UHFFFAOYSA-N 50343793 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-1H-indole-2-carboxamide::CHEMBL1774535 D(2) dopamine receptor Homo sapiens 526 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343793&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248213 131346729 CHEMBL1774535 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639797 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc-3c(Cc4ccccc-34)c2)CC1 InChI=1S/C29H32FN3O2/c1-35-28-9-5-4-8-27(28)33-16-14-32(15-17-33)20-24(30)12-13-31-29(34)22-10-11-26-23(19-22)18-21-6-2-3-7-25(21)26/h2-11,19,24H,12-18,20H2,1H3,(H,31,34) QULJKIQETSQZKV-UHFFFAOYSA-N 50343786 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide::CHEMBL1774536 D(2) dopamine receptor Homo sapiens 2890 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343786&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248256 131346722 CHEMBL1774536 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639798 FC(CCNC(=O)c1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H28Cl2FN3O/c29-25-6-3-7-26(27(25)30)34-14-12-33(13-15-34)18-22(31)10-11-32-28(35)20-8-9-24-21(17-20)16-19-4-1-2-5-23(19)24/h1-9,17,22H,10-16,18H2,(H,32,35) GTBCNDPVHSBZNR-UHFFFAOYSA-N 50343794 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-9H-fluorene-2-carboxamide::CHEMBL1774537 D(2) dopamine receptor Homo sapiens 4260 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343794&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248257 131346730 CHEMBL1774537 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639799 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1 InChI=1S/C24H28FN3O2S/c1-30-21-8-4-3-7-20(21)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-5-9-22(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) DSOWHOSHPUSGFM-UHFFFAOYSA-N 50343795 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774538 D(2) dopamine receptor Homo sapiens 241 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343795&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248258 131346731 CHEMBL1774538 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639800 FC(CCNC(=O)c1cc2ccccc2s1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3OS/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LIJLYDMKDQLIKS-UHFFFAOYSA-N 50343796 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774539 D(2) dopamine receptor Homo sapiens 472 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343796&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248259 131346732 CHEMBL1774539 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639801 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H31FN4O3/c1-32-20-7-8-21-18(15-20)16-22(28-21)25(31)27-10-9-19(26)17-29-11-13-30(14-12-29)23-5-3-4-6-24(23)33-2/h3-8,15-16,19,28H,9-14,17H2,1-2H3,(H,27,31) XUBVWPDKERMCAP-UHFFFAOYSA-N 50343797 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774540 D(2) dopamine receptor Homo sapiens 302 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343797&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248260 131346733 CHEMBL1774540 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639802 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H27Cl2FN4O2/c1-33-18-5-6-20-16(13-18)14-21(29-20)24(32)28-8-7-17(27)15-30-9-11-31(12-10-30)22-4-2-3-19(25)23(22)26/h2-6,13-14,17,29H,7-12,15H2,1H3,(H,28,32) WBGWXELVCBHOMZ-UHFFFAOYSA-N 50343798 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774541 D(2) dopamine receptor Homo sapiens 230 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343798&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248261 131346734 CHEMBL1774541 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639803 FC(CCNC(=O)c1ccc2ccccc2c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C25H26Cl2FN3O/c26-22-6-3-7-23(24(22)27)31-14-12-30(13-15-31)17-21(28)10-11-29-25(32)20-9-8-18-4-1-2-5-19(18)16-20/h1-9,16,21H,10-15,17H2,(H,29,32) CNIUTIHLBNEOKA-UHFFFAOYSA-N 50343799 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-2-naphthamide::CHEMBL1774542 D(2) dopamine receptor Homo sapiens 195 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343799&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248298 131346735 CHEMBL1774542 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639804 Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)-c3ccccn3)CC2)c1Cl InChI=1S/C26H26Cl2N4O/c27-22-6-5-8-24(25(22)28)32-18-16-31(17-19-32)15-4-3-14-30-26(33)21-11-9-20(10-12-21)23-7-1-2-13-29-23/h1-13H,14-19H2,(H,30,33) ZMYOIZHRXABMFZ-UHFFFAOYSA-N 50161214 PG-01037::N-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-but-2-enyl}-4-pyridin-2-yl-benzamide::N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)but-2-enyl)-4-(pyridin-2-yl)benzamide::CHEMBL180010 D(2) dopamine receptor Homo sapiens 93.3 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50161214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50161214&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11477180 104047571 CHEMBL180010 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639805 CCCN(CCCCN1CCN(CC1)c1ccccc1OC)Cc1csc2ccccc12 InChI=1S/C27H37N3OS/c1-3-14-29(21-23-22-32-27-13-7-4-10-24(23)27)16-9-8-15-28-17-19-30(20-18-28)25-11-5-6-12-26(25)31-2/h4-7,10-13,22H,3,8-9,14-21H2,1-2H3 VHLUWRVNDLKEND-UHFFFAOYSA-N 50343800 N-(Benzo[b]thiophen-2-ylmethyl)-4-(4-(2-methoxyphenyl)-piperazin-1-yl)-N-propylbutan-1-amine::CHEMBL1774543 D(2) dopamine receptor Homo sapiens 69.9 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343800 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343800&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54584336 131346736 CHEMBL1774543 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639806 CCCN(CCCCN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1csc2ccccc12 InChI=1S/C26H33Cl2N3S/c1-2-12-30(19-21-20-32-25-11-4-3-8-22(21)25)14-6-5-13-29-15-17-31(18-16-29)24-10-7-9-23(27)26(24)28/h3-4,7-11,20H,2,5-6,12-19H2,1H3 JHMYLCCZLFZGNF-UHFFFAOYSA-N 50343801 N-(Benzo[b]thiophen-2-ylmethyl)-4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-N-propylbutan-1-amine::CHEMBL1774544 D(2) dopamine receptor Homo sapiens 162 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343801 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343801&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54580387 131346737 CHEMBL1774544 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639807 CCCN(CCCCN1CCN(CC1)c1ccccc1OC)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C32H41N3O/c1-3-16-34(25-26-14-15-30-28(23-26)24-27-10-4-5-11-29(27)30)18-9-8-17-33-19-21-35(22-20-33)31-12-6-7-13-32(31)36-2/h4-7,10-15,23H,3,8-9,16-22,24-25H2,1-2H3 HUKSBDBJOJSVHS-UHFFFAOYSA-N 50343802 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2-methoxyphenyl)piperazin-1-yl)-N-propylbutan-1-amine::CHEMBL1774545 D(2) dopamine receptor Homo sapiens 196 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343802 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343802&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248345 131346738 CHEMBL1774545 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639808 CCCN(CCCCN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C31H37Cl2N3/c1-2-14-35(23-24-12-13-28-26(21-24)22-25-8-3-4-9-27(25)28)16-6-5-15-34-17-19-36(20-18-34)30-11-7-10-29(32)31(30)33/h3-4,7-13,21H,2,5-6,14-20,22-23H2,1H3 PMHUNJLVEGNLQB-UHFFFAOYSA-N 50343803 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-N-propylbutan-1-amine::CHEMBL1774546 D(2) dopamine receptor Homo sapiens 269 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343803&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248346 131346739 CHEMBL1774546 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639809 CCCN(CCCCN1CCN(CC1)c1ccccc1OC)Cc1ccc2ccccc2c1 InChI=1S/C29H39N3O/c1-3-16-31(24-25-14-15-26-10-4-5-11-27(26)23-25)18-9-8-17-30-19-21-32(22-20-30)28-12-6-7-13-29(28)33-2/h4-7,10-15,23H,3,8-9,16-22,24H2,1-2H3 PLFUSXITMGZVCU-UHFFFAOYSA-N 50343804 4-(4-(2-Methoxyphenyl)piperazin-1-yl)-N-(naphthalen-2-ylmethyl)-N-propylbutan-1-amine::CHEMBL1774547 D(2) dopamine receptor Homo sapiens 119 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343804 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343804&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248347 131346740 CHEMBL1774547 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639810 CCCN(CCCCN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc2ccccc2c1 InChI=1S/C28H35Cl2N3/c1-2-14-32(22-23-12-13-24-8-3-4-9-25(24)21-23)16-6-5-15-31-17-19-33(20-18-31)27-11-7-10-26(29)28(27)30/h3-4,7-13,21H,2,5-6,14-20,22H2,1H3 IEYDEPWJEHAEPC-UHFFFAOYSA-N 50343805 4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-N-(naphthalen-2-ylmethyl)-N-propylbutan-1-amine::CHEMBL1774548 D(2) dopamine receptor Homo sapiens 313 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343805 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343805&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248348 131346741 CHEMBL1774548 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639811 OC(CCNCc1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H31Cl2N3O/c29-26-6-3-7-27(28(26)30)33-14-12-32(13-15-33)19-23(34)10-11-31-18-20-8-9-25-22(16-20)17-21-4-1-2-5-24(21)25/h1-9,16,23,31,34H,10-15,17-19H2 VLTGPTYNYZEWJR-UHFFFAOYSA-N 50343806 4-(((9H-Fluoren-2-yl)methyl)amino)-1-(4-(2,3-dichlorophenyl)piperazin-1-yl)butan-2-ol::CHEMBL1774549 D(2) dopamine receptor Homo sapiens 2090 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343806 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343806&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248349 131346742 CHEMBL1774549 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639812 FC(CCNCc1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H30Cl2FN3/c29-26-6-3-7-27(28(26)30)34-14-12-33(13-15-34)19-23(31)10-11-32-18-20-8-9-25-22(16-20)17-21-4-1-2-5-24(21)25/h1-9,16,23,32H,10-15,17-19H2 FVIINRQKSXAKLE-UHFFFAOYSA-N 50343807 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-3-fluorobutan-1-amine::CHEMBL1774550 D(2) dopamine receptor Homo sapiens 5270 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343807 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343807&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248393 131346743 CHEMBL1774550 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639813 CN(CCC(O)CN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C29H33Cl2N3O/c1-32(19-21-9-10-26-23(17-21)18-22-5-2-3-6-25(22)26)12-11-24(35)20-33-13-15-34(16-14-33)28-8-4-7-27(30)29(28)31/h2-10,17,24,35H,11-16,18-20H2,1H3 QJIHBQHUALITFU-UHFFFAOYSA-N 50343808 4-(((9H-Fluoren-2-yl)methyl)(methyl)amino)-1-(4-(2,3-dichlorophenyl)piperazin-1-yl)butan-2-ol::CHEMBL1774551 D(2) dopamine receptor Homo sapiens 869 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343808 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343808&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248394 131346744 CHEMBL1774551 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639814 CN(CCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C29H32Cl2FN3/c1-33(19-21-9-10-26-23(17-21)18-22-5-2-3-6-25(22)26)12-11-24(32)20-34-13-15-35(16-14-34)28-8-4-7-27(30)29(28)31/h2-10,17,24H,11-16,18-20H2,1H3 KROSHEKWTTXFGB-UHFFFAOYSA-N 50343809 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-3-fluoro-N-methylbutan-1-amine::CHEMBL1773087 D(2) dopamine receptor Homo sapiens 2060 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343809&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248395 131346745 CHEMBL1773087 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639815 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1 InChI=1S/C26H31N3O2/c1-31-25-11-5-4-10-24(25)29-18-16-28(17-19-29)15-7-6-14-27-26(30)23-13-12-21-8-2-3-9-22(21)20-23/h2-5,8-13,20H,6-7,14-19H2,1H3,(H,27,30) MNHDKMDLOJSCGN-UHFFFAOYSA-N 50119380 CHEMBL540612::N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-2-naphthamide::CHEMBL25236::Naphthalene-2-carboxylic acid {4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-butyl}-amide D(2) dopamine receptor Homo sapiens 33.6 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50119380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50119380&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 3038495 104012598 CHEMBL25236CHEMBL540612 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639816 Clc1cccc(N2CCN(CCCCNC(=O)c3ccc-4c(Cc5ccccc-45)c3)CC2)c1Cl InChI=1S/C28H29Cl2N3O/c29-25-8-5-9-26(27(25)30)33-16-14-32(15-17-33)13-4-3-12-31-28(34)21-10-11-24-22(19-21)18-20-6-1-2-7-23(20)24/h1-2,5-11,19H,3-4,12-18H2,(H,31,34) YJPWVCIGSHWNON-UHFFFAOYSA-N 50071959 9H-Fluorene-2-carboxylic acid {4-[4-(2,3-dichloro-phenyl)-piperazin-1-yl]-butyl}-amide::N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide::CHEMBL300780 D(2) dopamine receptor Homo sapiens 112 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50071959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50071959&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 9891901 103965649 CHEMBL300780 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639817 Clc1cccc(N2CCN(CCCCNC(=O)c3csc4ccccc34)CC2)c1Cl InChI=1S/C23H25Cl2N3OS/c24-19-7-5-8-20(22(19)25)28-14-12-27(13-15-28)11-4-3-10-26-23(29)18-16-30-21-9-2-1-6-17(18)21/h1-2,5-9,16H,3-4,10-15H2,(H,26,29) DCFGDYDTTWPOBM-UHFFFAOYSA-N 50343810 benzo[b]thiophene-2-carboxylic acid{4-[4-(2,3-dichlorophenyl)-piperazin-1-yl]butyl}amide::CHEMBL1774552 D(2) dopamine receptor Homo sapiens 64.7 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343810 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343810&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54585306 131346746 CHEMBL1774552 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639818 Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C23H25Cl2N3O2/c24-18-7-5-8-19(22(18)25)28-14-12-27(13-15-28)11-4-3-10-26-23(29)21-16-17-6-1-2-9-20(17)30-21/h1-2,5-9,16H,3-4,10-15H2,(H,26,29) YJYMXCFUNVLJOC-UHFFFAOYSA-N 50119384 Benzofuran-2-carboxylic acid {4-[4-(2,3-dichloro-phenyl)-piperazin-1-yl]-butyl}-amide::N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide::CHEMBL139926 D(2) dopamine receptor Homo sapiens 44.8 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50119384 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50119384&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 9980998 104012602 CHEMBL139926 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639819 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(cc2)-c2ccccn2)CC1 InChI=1S/C27H31FN4O2/c1-34-26-8-3-2-7-25(26)32-18-16-31(17-19-32)20-23(28)13-15-30-27(33)22-11-9-21(10-12-22)24-6-4-5-14-29-24/h2-12,14,23H,13,15-20H2,1H3,(H,30,33) DXTFDOIEUMNMMV-UHFFFAOYSA-N 50343787 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-6-phenylnicotinamide::CHEMBL1774383 D(3) dopamine receptor Homo sapiens 20.5 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343787&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248158 131346723 CHEMBL1774383 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639820 FC(CCNC(=O)c1ccc(cc1)-c1ccccn1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C26H27Cl2FN4O/c27-22-4-3-6-24(25(22)28)33-16-14-32(15-17-33)18-21(29)11-13-31-26(34)20-9-7-19(8-10-20)23-5-1-2-12-30-23/h1-10,12,21H,11,13-18H2,(H,31,34) DUYVMDDLFWXUHZ-UHFFFAOYSA-N 50343788 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-6-phenylnicotinamide::CHEMBL1774384 D(3) dopamine receptor Homo sapiens 6.2 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343788&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248159 131346724 CHEMBL1774384 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639821 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C24H28FN3O3/c1-30-22-9-5-3-7-20(22)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-4-8-21(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) VGOPWFPTLSPLJJ-UHFFFAOYSA-N 50343789 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzofuran-2-carboxamide::CHEMBL1774385 D(3) dopamine receptor Homo sapiens 28.6 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343789&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248208 131346725 CHEMBL1774385 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639822 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 D(3) dopamine receptor Homo sapiens 6.1 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639823 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H30FN3O4/c1-31-20-7-8-22-18(15-20)16-24(33-22)25(30)27-10-9-19(26)17-28-11-13-29(14-12-28)21-5-3-4-6-23(21)32-2/h3-8,15-16,19H,9-14,17H2,1-2H3,(H,27,30) CSQTYZHHBNDDMS-UHFFFAOYSA-N 50343790 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774532 D(3) dopamine receptor Homo sapiens 13.9 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343790&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248210 131346726 CHEMBL1774532 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639824 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H26Cl2FN3O3/c1-32-18-5-6-21-16(13-18)14-22(33-21)24(31)28-8-7-17(27)15-29-9-11-30(12-10-29)20-4-2-3-19(25)23(20)26/h2-6,13-14,17H,7-12,15H2,1H3,(H,28,31) TXDNMFSXILPGFK-UHFFFAOYSA-N 50343791 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774533 D(3) dopamine receptor Homo sapiens 8 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343791&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248211 131346727 CHEMBL1774533 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639825 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C24H29FN4O2/c1-31-23-9-5-4-8-22(23)29-14-12-28(13-15-29)17-19(25)10-11-26-24(30)21-16-18-6-2-3-7-20(18)27-21/h2-9,16,19,27H,10-15,17H2,1H3,(H,26,30) JLMZACVBNICYMZ-UHFFFAOYSA-N 50343792 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide::CHEMBL1774534 D(3) dopamine receptor Homo sapiens 9.5 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343792&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248212 131346728 CHEMBL1774534 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639826 FC(CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H25Cl2FN4O/c24-18-5-3-7-21(22(18)25)30-12-10-29(11-13-30)15-17(26)8-9-27-23(31)20-14-16-4-1-2-6-19(16)28-20/h1-7,14,17,28H,8-13,15H2,(H,27,31) VIHBCLOGDPFGGP-UHFFFAOYSA-N 50343793 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-1H-indole-2-carboxamide::CHEMBL1774535 D(3) dopamine receptor Homo sapiens 4 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343793&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248213 131346729 CHEMBL1774535 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639827 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc-3c(Cc4ccccc-34)c2)CC1 InChI=1S/C29H32FN3O2/c1-35-28-9-5-4-8-27(28)33-16-14-32(15-17-33)20-24(30)12-13-31-29(34)22-10-11-26-23(19-22)18-21-6-2-3-7-25(21)26/h2-11,19,24H,12-18,20H2,1H3,(H,31,34) QULJKIQETSQZKV-UHFFFAOYSA-N 50343786 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide::CHEMBL1774536 D(3) dopamine receptor Homo sapiens 10.1 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343786&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248256 131346722 CHEMBL1774536 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639828 FC(CCNC(=O)c1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H28Cl2FN3O/c29-25-6-3-7-26(27(25)30)34-14-12-33(13-15-34)18-22(31)10-11-32-28(35)20-8-9-24-21(17-20)16-19-4-1-2-5-23(19)24/h1-9,17,22H,10-16,18H2,(H,32,35) GTBCNDPVHSBZNR-UHFFFAOYSA-N 50343794 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-9H-fluorene-2-carboxamide::CHEMBL1774537 D(3) dopamine receptor Homo sapiens 2.6 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343794&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248257 131346730 CHEMBL1774537 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639829 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1 InChI=1S/C24H28FN3O2S/c1-30-21-8-4-3-7-20(21)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-5-9-22(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) DSOWHOSHPUSGFM-UHFFFAOYSA-N 50343795 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774538 D(3) dopamine receptor Homo sapiens 3.8 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343795&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248258 131346731 CHEMBL1774538 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639830 FC(CCNC(=O)c1cc2ccccc2s1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3OS/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LIJLYDMKDQLIKS-UHFFFAOYSA-N 50343796 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774539 D(3) dopamine receptor Homo sapiens 2.9 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343796&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248259 131346732 CHEMBL1774539 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639831 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H31FN4O3/c1-32-20-7-8-21-18(15-20)16-22(28-21)25(31)27-10-9-19(26)17-29-11-13-30(14-12-29)23-5-3-4-6-24(23)33-2/h3-8,15-16,19,28H,9-14,17H2,1-2H3,(H,27,31) XUBVWPDKERMCAP-UHFFFAOYSA-N 50343797 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774540 D(3) dopamine receptor Homo sapiens 4.6 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343797&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248260 131346733 CHEMBL1774540 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639832 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H27Cl2FN4O2/c1-33-18-5-6-20-16(13-18)14-21(29-20)24(32)28-8-7-17(27)15-30-9-11-31(12-10-30)22-4-2-3-19(25)23(22)26/h2-6,13-14,17,29H,7-12,15H2,1H3,(H,28,32) WBGWXELVCBHOMZ-UHFFFAOYSA-N 50343798 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774541 D(3) dopamine receptor Homo sapiens 1.5 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343798&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248261 131346734 CHEMBL1774541 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639833 FC(CCNC(=O)c1ccc2ccccc2c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C25H26Cl2FN3O/c26-22-6-3-7-23(24(22)27)31-14-12-30(13-15-31)17-21(28)10-11-29-25(32)20-9-8-18-4-1-2-5-19(18)16-20/h1-9,16,21H,10-15,17H2,(H,29,32) CNIUTIHLBNEOKA-UHFFFAOYSA-N 50343799 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-2-naphthamide::CHEMBL1774542 D(3) dopamine receptor Homo sapiens 6.1 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343799&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248298 131346735 CHEMBL1774542 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639834 Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)-c3ccccn3)CC2)c1Cl InChI=1S/C26H26Cl2N4O/c27-22-6-5-8-24(25(22)28)32-18-16-31(17-19-32)15-4-3-14-30-26(33)21-11-9-20(10-12-21)23-7-1-2-13-29-23/h1-13H,14-19H2,(H,30,33) ZMYOIZHRXABMFZ-UHFFFAOYSA-N 50161214 PG-01037::N-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-but-2-enyl}-4-pyridin-2-yl-benzamide::N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)but-2-enyl)-4-(pyridin-2-yl)benzamide::CHEMBL180010 D(3) dopamine receptor Homo sapiens 0.7 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50161214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50161214&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11477180 104047571 CHEMBL180010 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639835 CCCN(CCCCN1CCN(CC1)c1ccccc1OC)Cc1csc2ccccc12 InChI=1S/C27H37N3OS/c1-3-14-29(21-23-22-32-27-13-7-4-10-24(23)27)16-9-8-15-28-17-19-30(20-18-28)25-11-5-6-12-26(25)31-2/h4-7,10-13,22H,3,8-9,14-21H2,1-2H3 VHLUWRVNDLKEND-UHFFFAOYSA-N 50343800 N-(Benzo[b]thiophen-2-ylmethyl)-4-(4-(2-methoxyphenyl)-piperazin-1-yl)-N-propylbutan-1-amine::CHEMBL1774543 D(3) dopamine receptor Homo sapiens 67.9 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343800 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343800&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54584336 131346736 CHEMBL1774543 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639836 CCCN(CCCCN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1csc2ccccc12 InChI=1S/C26H33Cl2N3S/c1-2-12-30(19-21-20-32-25-11-4-3-8-22(21)25)14-6-5-13-29-15-17-31(18-16-29)24-10-7-9-23(27)26(24)28/h3-4,7-11,20H,2,5-6,12-19H2,1H3 JHMYLCCZLFZGNF-UHFFFAOYSA-N 50343801 N-(Benzo[b]thiophen-2-ylmethyl)-4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-N-propylbutan-1-amine::CHEMBL1774544 D(3) dopamine receptor Homo sapiens 101 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343801 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343801&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54580387 131346737 CHEMBL1774544 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639837 CCCN(CCCCN1CCN(CC1)c1ccccc1OC)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C32H41N3O/c1-3-16-34(25-26-14-15-30-28(23-26)24-27-10-4-5-11-29(27)30)18-9-8-17-33-19-21-35(22-20-33)31-12-6-7-13-32(31)36-2/h4-7,10-15,23H,3,8-9,16-22,24-25H2,1-2H3 HUKSBDBJOJSVHS-UHFFFAOYSA-N 50343802 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2-methoxyphenyl)piperazin-1-yl)-N-propylbutan-1-amine::CHEMBL1774545 D(3) dopamine receptor Homo sapiens 71.5 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343802 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343802&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248345 131346738 CHEMBL1774545 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639838 CCCN(CCCCN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C31H37Cl2N3/c1-2-14-35(23-24-12-13-28-26(21-24)22-25-8-3-4-9-27(25)28)16-6-5-15-34-17-19-36(20-18-34)30-11-7-10-29(32)31(30)33/h3-4,7-13,21H,2,5-6,14-20,22-23H2,1H3 PMHUNJLVEGNLQB-UHFFFAOYSA-N 50343803 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-N-propylbutan-1-amine::CHEMBL1774546 D(3) dopamine receptor Homo sapiens 129 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343803&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248346 131346739 CHEMBL1774546 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639839 CCCN(CCCCN1CCN(CC1)c1ccccc1OC)Cc1ccc2ccccc2c1 InChI=1S/C29H39N3O/c1-3-16-31(24-25-14-15-26-10-4-5-11-27(26)23-25)18-9-8-17-30-19-21-32(22-20-30)28-12-6-7-13-29(28)33-2/h4-7,10-15,23H,3,8-9,16-22,24H2,1-2H3 PLFUSXITMGZVCU-UHFFFAOYSA-N 50343804 4-(4-(2-Methoxyphenyl)piperazin-1-yl)-N-(naphthalen-2-ylmethyl)-N-propylbutan-1-amine::CHEMBL1774547 D(3) dopamine receptor Homo sapiens 80.8 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343804 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343804&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248347 131346740 CHEMBL1774547 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639840 CCCN(CCCCN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc2ccccc2c1 InChI=1S/C28H35Cl2N3/c1-2-14-32(22-23-12-13-24-8-3-4-9-25(24)21-23)16-6-5-15-31-17-19-33(20-18-31)27-11-7-10-26(29)28(27)30/h3-4,7-13,21H,2,5-6,14-20,22H2,1H3 IEYDEPWJEHAEPC-UHFFFAOYSA-N 50343805 4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-N-(naphthalen-2-ylmethyl)-N-propylbutan-1-amine::CHEMBL1774548 D(3) dopamine receptor Homo sapiens 104 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343805 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343805&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248348 131346741 CHEMBL1774548 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639841 OC(CCNCc1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H31Cl2N3O/c29-26-6-3-7-27(28(26)30)33-14-12-32(13-15-33)19-23(34)10-11-31-18-20-8-9-25-22(16-20)17-21-4-1-2-5-24(21)25/h1-9,16,23,31,34H,10-15,17-19H2 VLTGPTYNYZEWJR-UHFFFAOYSA-N 50343806 4-(((9H-Fluoren-2-yl)methyl)amino)-1-(4-(2,3-dichlorophenyl)piperazin-1-yl)butan-2-ol::CHEMBL1774549 D(3) dopamine receptor Homo sapiens 134 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343806 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343806&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248349 131346742 CHEMBL1774549 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639842 FC(CCNCc1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H30Cl2FN3/c29-26-6-3-7-27(28(26)30)34-14-12-33(13-15-34)19-23(31)10-11-32-18-20-8-9-25-22(16-20)17-21-4-1-2-5-24(21)25/h1-9,16,23,32H,10-15,17-19H2 FVIINRQKSXAKLE-UHFFFAOYSA-N 50343807 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-3-fluorobutan-1-amine::CHEMBL1774550 D(3) dopamine receptor Homo sapiens 467 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343807 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343807&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248393 131346743 CHEMBL1774550 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639843 CN(CCC(O)CN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C29H33Cl2N3O/c1-32(19-21-9-10-26-23(17-21)18-22-5-2-3-6-25(22)26)12-11-24(35)20-33-13-15-34(16-14-33)28-8-4-7-27(30)29(28)31/h2-10,17,24,35H,11-16,18-20H2,1H3 QJIHBQHUALITFU-UHFFFAOYSA-N 50343808 4-(((9H-Fluoren-2-yl)methyl)(methyl)amino)-1-(4-(2,3-dichlorophenyl)piperazin-1-yl)butan-2-ol::CHEMBL1774551 D(3) dopamine receptor Homo sapiens 162 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343808 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343808&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248394 131346744 CHEMBL1774551 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639844 CN(CCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C29H32Cl2FN3/c1-33(19-21-9-10-26-23(17-21)18-22-5-2-3-6-25(22)26)12-11-24(32)20-34-13-15-35(16-14-34)28-8-4-7-27(30)29(28)31/h2-10,17,24H,11-16,18-20H2,1H3 KROSHEKWTTXFGB-UHFFFAOYSA-N 50343809 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-3-fluoro-N-methylbutan-1-amine::CHEMBL1773087 D(3) dopamine receptor Homo sapiens 393 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343809&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248395 131346745 CHEMBL1773087 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639845 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1 InChI=1S/C26H31N3O2/c1-31-25-11-5-4-10-24(25)29-18-16-28(17-19-29)15-7-6-14-27-26(30)23-13-12-21-8-2-3-9-22(21)20-23/h2-5,8-13,20H,6-7,14-19H2,1H3,(H,27,30) MNHDKMDLOJSCGN-UHFFFAOYSA-N 50119380 CHEMBL540612::N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-2-naphthamide::CHEMBL25236::Naphthalene-2-carboxylic acid {4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-butyl}-amide D(3) dopamine receptor Homo sapiens 0.3 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50119380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50119380&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 3038495 104012598 CHEMBL25236CHEMBL540612 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639846 Clc1cccc(N2CCN(CCCCNC(=O)c3ccc-4c(Cc5ccccc-45)c3)CC2)c1Cl InChI=1S/C28H29Cl2N3O/c29-25-8-5-9-26(27(25)30)33-16-14-32(15-17-33)13-4-3-12-31-28(34)21-10-11-24-22(19-21)18-20-6-1-2-7-23(20)24/h1-2,5-11,19H,3-4,12-18H2,(H,31,34) YJPWVCIGSHWNON-UHFFFAOYSA-N 50071959 9H-Fluorene-2-carboxylic acid {4-[4-(2,3-dichloro-phenyl)-piperazin-1-yl]-butyl}-amide::N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide::CHEMBL300780 D(3) dopamine receptor Homo sapiens 2 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50071959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50071959&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 9891901 103965649 CHEMBL300780 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639847 Clc1cccc(N2CCN(CCCCNC(=O)c3csc4ccccc34)CC2)c1Cl InChI=1S/C23H25Cl2N3OS/c24-19-7-5-8-20(22(19)25)28-14-12-27(13-15-28)11-4-3-10-26-23(29)18-16-30-21-9-2-1-6-17(18)21/h1-2,5-9,16H,3-4,10-15H2,(H,26,29) DCFGDYDTTWPOBM-UHFFFAOYSA-N 50343810 benzo[b]thiophene-2-carboxylic acid{4-[4-(2,3-dichlorophenyl)-piperazin-1-yl]butyl}amide::CHEMBL1774552 D(3) dopamine receptor Homo sapiens 0.8 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343810 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343810&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54585306 131346746 CHEMBL1774552 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639848 Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1Cl InChI=1S/C23H25Cl2N3O2/c24-18-7-5-8-19(22(18)25)28-14-12-27(13-15-28)11-4-3-10-26-23(29)21-16-17-6-1-2-9-20(17)30-21/h1-2,5-9,16H,3-4,10-15H2,(H,26,29) YJYMXCFUNVLJOC-UHFFFAOYSA-N 50119384 Benzofuran-2-carboxylic acid {4-[4-(2,3-dichloro-phenyl)-piperazin-1-yl]-butyl}-amide::N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide::CHEMBL139926 D(3) dopamine receptor Homo sapiens 0.8 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50119384 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50119384&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 9980998 104012602 CHEMBL139926 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639849 FC(CCNC(=O)c1ccc(cc1)-c1ccccn1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C26H27Cl2FN4O/c27-22-4-3-6-24(25(22)28)33-16-14-32(15-17-33)18-21(29)11-13-31-26(34)20-9-7-19(8-10-20)23-5-1-2-12-30-23/h1-10,12,21H,11,13-18H2,(H,31,34) DUYVMDDLFWXUHZ-UHFFFAOYSA-N 50343788 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-6-phenylnicotinamide::CHEMBL1774384 D(4) dopamine receptor Homo sapiens 3090 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343788&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248159 131346724 CHEMBL1774384 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 50639850 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 D(4) dopamine receptor Homo sapiens 5340 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 50639851 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C24H29FN4O2/c1-31-23-9-5-4-8-22(23)29-14-12-28(13-15-29)17-19(25)10-11-26-24(30)21-16-18-6-2-3-7-20(18)27-21/h2-9,16,19,27H,10-15,17H2,1H3,(H,26,30) JLMZACVBNICYMZ-UHFFFAOYSA-N 50343792 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide::CHEMBL1774534 D(4) dopamine receptor Homo sapiens 1490 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343792&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248212 131346728 CHEMBL1774534 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 50639852 FC(CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H25Cl2FN4O/c24-18-5-3-7-21(22(18)25)30-12-10-29(11-13-30)15-17(26)8-9-27-23(31)20-14-16-4-1-2-6-19(16)28-20/h1-7,14,17,28H,8-13,15H2,(H,27,31) VIHBCLOGDPFGGP-UHFFFAOYSA-N 50343793 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-1H-indole-2-carboxamide::CHEMBL1774535 D(4) dopamine receptor Homo sapiens 3360 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343793&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248213 131346729 CHEMBL1774535 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 50639853 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc-3c(Cc4ccccc-34)c2)CC1 InChI=1S/C29H32FN3O2/c1-35-28-9-5-4-8-27(28)33-16-14-32(15-17-33)20-24(30)12-13-31-29(34)22-10-11-26-23(19-22)18-21-6-2-3-7-25(21)26/h2-11,19,24H,12-18,20H2,1H3,(H,31,34) QULJKIQETSQZKV-UHFFFAOYSA-N 50343786 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide::CHEMBL1774536 D(4) dopamine receptor Homo sapiens 3180 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343786&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248256 131346722 CHEMBL1774536 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 50639854 Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc(cc3)-c3ccccn3)CC2)c1Cl InChI=1S/C26H26Cl2N4O/c27-22-6-5-8-24(25(22)28)32-18-16-31(17-19-32)15-4-3-14-30-26(33)21-11-9-20(10-12-21)23-7-1-2-13-29-23/h1-13H,14-19H2,(H,30,33) ZMYOIZHRXABMFZ-UHFFFAOYSA-N 50161214 PG-01037::N-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-but-2-enyl}-4-pyridin-2-yl-benzamide::N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)but-2-enyl)-4-(pyridin-2-yl)benzamide::CHEMBL180010 D(4) dopamine receptor Homo sapiens 375 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50161214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50161214&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 11477180 104047571 CHEMBL180010 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC D(4) dopamine receptor DRD4_HUMAN P21917 B0M0J7 Q7Z7Q5 Q8NGM5 50639855 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(cc2)-c2ccccn2)CC1 InChI=1S/C27H31FN4O2/c1-34-26-8-3-2-7-25(26)32-18-16-31(17-19-32)20-23(28)13-15-30-27(33)22-11-9-21(10-12-22)24-6-4-5-14-29-24/h2-12,14,23H,13,15-20H2,1H3,(H,30,33) DXTFDOIEUMNMMV-UHFFFAOYSA-N 50343787 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-6-phenylnicotinamide::CHEMBL1774383 D(3) dopamine receptor Homo sapiens 390 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343787&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248158 131346723 CHEMBL1774383 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639856 FC(CCNC(=O)c1ccc(cc1)-c1ccccn1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C26H27Cl2FN4O/c27-22-4-3-6-24(25(22)28)33-16-14-32(15-17-33)18-21(29)11-13-31-26(34)20-9-7-19(8-10-20)23-5-1-2-12-30-23/h1-10,12,21H,11,13-18H2,(H,31,34) DUYVMDDLFWXUHZ-UHFFFAOYSA-N 50343788 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-6-phenylnicotinamide::CHEMBL1774384 D(3) dopamine receptor Homo sapiens 256 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343788&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248159 131346724 CHEMBL1774384 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639857 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C24H28FN3O3/c1-30-22-9-5-3-7-20(22)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-4-8-21(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) VGOPWFPTLSPLJJ-UHFFFAOYSA-N 50343789 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzofuran-2-carboxamide::CHEMBL1774385 D(3) dopamine receptor Homo sapiens 440 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343789&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248208 131346725 CHEMBL1774385 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639858 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 D(3) dopamine receptor Homo sapiens 430 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639859 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H30FN3O4/c1-31-20-7-8-22-18(15-20)16-24(33-22)25(30)27-10-9-19(26)17-28-11-13-29(14-12-28)21-5-3-4-6-23(21)32-2/h3-8,15-16,19H,9-14,17H2,1-2H3,(H,27,30) CSQTYZHHBNDDMS-UHFFFAOYSA-N 50343790 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774532 D(3) dopamine receptor Homo sapiens 780 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343790&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248210 131346726 CHEMBL1774532 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639860 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H26Cl2FN3O3/c1-32-18-5-6-21-16(13-18)14-22(33-21)24(31)28-8-7-17(27)15-29-9-11-30(12-10-29)20-4-2-3-19(25)23(20)26/h2-6,13-14,17H,7-12,15H2,1H3,(H,28,31) TXDNMFSXILPGFK-UHFFFAOYSA-N 50343791 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774533 D(3) dopamine receptor Homo sapiens 1430 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343791&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248211 131346727 CHEMBL1774533 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639861 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C24H29FN4O2/c1-31-23-9-5-4-8-22(23)29-14-12-28(13-15-29)17-19(25)10-11-26-24(30)21-16-18-6-2-3-7-20(18)27-21/h2-9,16,19,27H,10-15,17H2,1H3,(H,26,30) JLMZACVBNICYMZ-UHFFFAOYSA-N 50343792 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide::CHEMBL1774534 D(3) dopamine receptor Homo sapiens 820 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343792&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248212 131346728 CHEMBL1774534 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639862 FC(CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H25Cl2FN4O/c24-18-5-3-7-21(22(18)25)30-12-10-29(11-13-30)15-17(26)8-9-27-23(31)20-14-16-4-1-2-6-19(16)28-20/h1-7,14,17,28H,8-13,15H2,(H,27,31) VIHBCLOGDPFGGP-UHFFFAOYSA-N 50343793 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-1H-indole-2-carboxamide::CHEMBL1774535 D(3) dopamine receptor Homo sapiens 520 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343793&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248213 131346729 CHEMBL1774535 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639863 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc-3c(Cc4ccccc-34)c2)CC1 InChI=1S/C29H32FN3O2/c1-35-28-9-5-4-8-27(28)33-16-14-32(15-17-33)20-24(30)12-13-31-29(34)22-10-11-26-23(19-22)18-21-6-2-3-7-25(21)26/h2-11,19,24H,12-18,20H2,1H3,(H,31,34) QULJKIQETSQZKV-UHFFFAOYSA-N 50343786 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide::CHEMBL1774536 D(3) dopamine receptor Homo sapiens 214 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343786&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248256 131346722 CHEMBL1774536 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639864 FC(CCNC(=O)c1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H28Cl2FN3O/c29-25-6-3-7-26(27(25)30)34-14-12-33(13-15-34)18-22(31)10-11-32-28(35)20-8-9-24-21(17-20)16-19-4-1-2-5-23(19)24/h1-9,17,22H,10-16,18H2,(H,32,35) GTBCNDPVHSBZNR-UHFFFAOYSA-N 50343794 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-9H-fluorene-2-carboxamide::CHEMBL1774537 D(3) dopamine receptor Homo sapiens 800 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343794&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248257 131346730 CHEMBL1774537 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639865 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1 InChI=1S/C24H28FN3O2S/c1-30-21-8-4-3-7-20(21)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-5-9-22(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) DSOWHOSHPUSGFM-UHFFFAOYSA-N 50343795 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774538 D(3) dopamine receptor Homo sapiens 83 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343795&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248258 131346731 CHEMBL1774538 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639866 FC(CCNC(=O)c1cc2ccccc2s1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3OS/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LIJLYDMKDQLIKS-UHFFFAOYSA-N 50343796 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774539 D(3) dopamine receptor Homo sapiens 17 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343796&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248259 131346732 CHEMBL1774539 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639867 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H31FN4O3/c1-32-20-7-8-21-18(15-20)16-22(28-21)25(31)27-10-9-19(26)17-29-11-13-30(14-12-29)23-5-3-4-6-24(23)33-2/h3-8,15-16,19,28H,9-14,17H2,1-2H3,(H,27,31) XUBVWPDKERMCAP-UHFFFAOYSA-N 50343797 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774540 D(3) dopamine receptor Homo sapiens 1140 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343797&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248260 131346733 CHEMBL1774540 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639868 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H27Cl2FN4O2/c1-33-18-5-6-20-16(13-18)14-21(29-20)24(32)28-8-7-17(27)15-30-9-11-31(12-10-30)22-4-2-3-19(25)23(22)26/h2-6,13-14,17,29H,7-12,15H2,1H3,(H,28,32) WBGWXELVCBHOMZ-UHFFFAOYSA-N 50343798 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774541 D(3) dopamine receptor Homo sapiens 320 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343798&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248261 131346734 CHEMBL1774541 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639869 FC(CCNC(=O)c1ccc2ccccc2c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C25H26Cl2FN3O/c26-22-6-3-7-23(24(22)27)31-14-12-30(13-15-31)17-21(28)10-11-29-25(32)20-9-8-18-4-1-2-5-19(18)16-20/h1-9,16,21H,10-15,17H2,(H,29,32) CNIUTIHLBNEOKA-UHFFFAOYSA-N 50343799 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-2-naphthamide::CHEMBL1774542 D(3) dopamine receptor Homo sapiens 255 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343799&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248298 131346735 CHEMBL1774542 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639870 CN(CCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C29H32Cl2FN3/c1-33(19-21-9-10-26-23(17-21)18-22-5-2-3-6-25(22)26)12-11-24(32)20-34-13-15-35(16-14-34)28-8-4-7-27(30)29(28)31/h2-10,17,24H,11-16,18-20H2,1H3 KROSHEKWTTXFGB-UHFFFAOYSA-N 50343809 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-3-fluoro-N-methylbutan-1-amine::CHEMBL1773087 D(3) dopamine receptor Homo sapiens 918 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343809&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248395 131346745 CHEMBL1773087 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639871 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21) BGRJTUBHPOOWDU-UHFFFAOYSA-N 11638 N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide::Sulpiride-R::SULPIRIDE,(+)::CHEMBL26::Compound 7::Sulpiride, SLP::SULPIRIDE,(-)::Sulpiride::US10172837, Sulpiride D(3) dopamine receptor Homo sapiens 66.22 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11638 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=11638&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 5355 46512161 CHEMBL26 DB00391 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639872 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H26Cl2FN3O3/c1-32-18-5-6-21-16(13-18)14-22(33-21)24(31)28-8-7-17(27)15-29-9-11-30(12-10-29)20-4-2-3-19(25)23(20)26/h2-6,13-14,17H,7-12,15H2,1H3,(H,28,31) TXDNMFSXILPGFK-UHFFFAOYSA-N 50343791 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774533 D(2) dopamine receptor Homo sapiens 1600 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343791&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248211 131346727 CHEMBL1774533 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639873 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1 InChI=1S/C24H28FN3O2S/c1-30-21-8-4-3-7-20(21)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-5-9-22(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) DSOWHOSHPUSGFM-UHFFFAOYSA-N 50343795 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774538 D(2) dopamine receptor Homo sapiens 421 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343795&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248258 131346731 CHEMBL1774538 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639874 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21) BGRJTUBHPOOWDU-UHFFFAOYSA-N 11638 N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide::Sulpiride-R::SULPIRIDE,(+)::CHEMBL26::Compound 7::Sulpiride, SLP::SULPIRIDE,(-)::Sulpiride::US10172837, Sulpiride D(2) dopamine receptor Homo sapiens 10.28 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11638 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=11638&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 5355 46512161 CHEMBL26 DB00391 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639875 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(cc2)-c2ccccn2)CC1 InChI=1S/C27H31FN4O2/c1-34-26-8-3-2-7-25(26)32-18-16-31(17-19-32)20-23(28)13-15-30-27(33)22-11-9-21(10-12-22)24-6-4-5-14-29-24/h2-12,14,23H,13,15-20H2,1H3,(H,30,33) DXTFDOIEUMNMMV-UHFFFAOYSA-N 50343787 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-6-phenylnicotinamide::CHEMBL1774383 D(3) dopamine receptor Homo sapiens 699 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343787&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248158 131346723 CHEMBL1774383 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639876 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H30FN3O4/c1-31-20-7-8-22-18(15-20)16-24(33-22)25(30)27-10-9-19(26)17-28-11-13-29(14-12-28)21-5-3-4-6-23(21)32-2/h3-8,15-16,19H,9-14,17H2,1-2H3,(H,27,30) CSQTYZHHBNDDMS-UHFFFAOYSA-N 50343790 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774532 D(3) dopamine receptor Homo sapiens 1240 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343790&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248210 131346726 CHEMBL1774532 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639877 FC(CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H25Cl2FN4O/c24-18-5-3-7-21(22(18)25)30-12-10-29(11-13-30)15-17(26)8-9-27-23(31)20-14-16-4-1-2-6-19(16)28-20/h1-7,14,17,28H,8-13,15H2,(H,27,31) VIHBCLOGDPFGGP-UHFFFAOYSA-N 50343793 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-1H-indole-2-carboxamide::CHEMBL1774535 D(3) dopamine receptor Homo sapiens 1220 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343793&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248213 131346729 CHEMBL1774535 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639878 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1 InChI=1S/C24H28FN3O2S/c1-30-21-8-4-3-7-20(21)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-5-9-22(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) DSOWHOSHPUSGFM-UHFFFAOYSA-N 50343795 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774538 D(3) dopamine receptor Homo sapiens 3210 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343795&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248258 131346731 CHEMBL1774538 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639879 FC(CCNC(=O)c1cc2ccccc2s1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3OS/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LIJLYDMKDQLIKS-UHFFFAOYSA-N 50343796 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774539 D(3) dopamine receptor Homo sapiens 3770 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343796&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248259 131346732 CHEMBL1774539 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639880 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H31FN4O3/c1-32-20-7-8-21-18(15-20)16-22(28-21)25(31)27-10-9-19(26)17-29-11-13-30(14-12-29)23-5-3-4-6-24(23)33-2/h3-8,15-16,19,28H,9-14,17H2,1-2H3,(H,27,31) XUBVWPDKERMCAP-UHFFFAOYSA-N 50343797 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774540 D(3) dopamine receptor Homo sapiens 2990 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343797&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248260 131346733 CHEMBL1774540 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639881 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21) BGRJTUBHPOOWDU-UHFFFAOYSA-N 11638 N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide::Sulpiride-R::SULPIRIDE,(+)::CHEMBL26::Compound 7::Sulpiride, SLP::SULPIRIDE,(-)::Sulpiride::US10172837, Sulpiride D(3) dopamine receptor Homo sapiens 560 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11638 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=11638&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 5355 46512161 CHEMBL26 DB00391 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639882 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(cc2)-c2ccccn2)CC1 InChI=1S/C27H31FN4O2/c1-34-26-8-3-2-7-25(26)32-18-16-31(17-19-32)20-23(28)13-15-30-27(33)22-11-9-21(10-12-22)24-6-4-5-14-29-24/h2-12,14,23H,13,15-20H2,1H3,(H,30,33) DXTFDOIEUMNMMV-UHFFFAOYSA-N 50343787 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-6-phenylnicotinamide::CHEMBL1774383 5-hydroxytryptamine receptor 1A Homo sapiens 49 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343787&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248158 131346723 CHEMBL1774383 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639883 FC(CCNC(=O)c1ccc(cc1)-c1ccccn1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C26H27Cl2FN4O/c27-22-4-3-6-24(25(22)28)33-16-14-32(15-17-33)18-21(29)11-13-31-26(34)20-9-7-19(8-10-20)23-5-1-2-12-30-23/h1-10,12,21H,11,13-18H2,(H,31,34) DUYVMDDLFWXUHZ-UHFFFAOYSA-N 50343788 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-6-phenylnicotinamide::CHEMBL1774384 5-hydroxytryptamine receptor 1A Homo sapiens 159 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343788&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248159 131346724 CHEMBL1774384 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639884 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C24H28FN3O3/c1-30-22-9-5-3-7-20(22)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-4-8-21(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) VGOPWFPTLSPLJJ-UHFFFAOYSA-N 50343789 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzofuran-2-carboxamide::CHEMBL1774385 5-hydroxytryptamine receptor 1A Homo sapiens 37.9 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343789&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248208 131346725 CHEMBL1774385 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639885 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 5-hydroxytryptamine receptor 1A Homo sapiens 1150 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639886 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H30FN3O4/c1-31-20-7-8-22-18(15-20)16-24(33-22)25(30)27-10-9-19(26)17-28-11-13-29(14-12-28)21-5-3-4-6-23(21)32-2/h3-8,15-16,19H,9-14,17H2,1-2H3,(H,27,30) CSQTYZHHBNDDMS-UHFFFAOYSA-N 50343790 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774532 5-hydroxytryptamine receptor 1A Homo sapiens 73 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343790&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248210 131346726 CHEMBL1774532 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639887 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H26Cl2FN3O3/c1-32-18-5-6-21-16(13-18)14-22(33-21)24(31)28-8-7-17(27)15-29-9-11-30(12-10-29)20-4-2-3-19(25)23(20)26/h2-6,13-14,17H,7-12,15H2,1H3,(H,28,31) TXDNMFSXILPGFK-UHFFFAOYSA-N 50343791 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774533 5-hydroxytryptamine receptor 1A Homo sapiens 501 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343791&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248211 131346727 CHEMBL1774533 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639888 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C24H29FN4O2/c1-31-23-9-5-4-8-22(23)29-14-12-28(13-15-29)17-19(25)10-11-26-24(30)21-16-18-6-2-3-7-20(18)27-21/h2-9,16,19,27H,10-15,17H2,1H3,(H,26,30) JLMZACVBNICYMZ-UHFFFAOYSA-N 50343792 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide::CHEMBL1774534 5-hydroxytryptamine receptor 1A Homo sapiens 101 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343792&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248212 131346728 CHEMBL1774534 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639889 FC(CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H25Cl2FN4O/c24-18-5-3-7-21(22(18)25)30-12-10-29(11-13-30)15-17(26)8-9-27-23(31)20-14-16-4-1-2-6-19(16)28-20/h1-7,14,17,28H,8-13,15H2,(H,27,31) VIHBCLOGDPFGGP-UHFFFAOYSA-N 50343793 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-1H-indole-2-carboxamide::CHEMBL1774535 5-hydroxytryptamine receptor 1A Homo sapiens 223 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343793&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248213 131346729 CHEMBL1774535 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639890 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc-3c(Cc4ccccc-34)c2)CC1 InChI=1S/C29H32FN3O2/c1-35-28-9-5-4-8-27(28)33-16-14-32(15-17-33)20-24(30)12-13-31-29(34)22-10-11-26-23(19-22)18-21-6-2-3-7-25(21)26/h2-11,19,24H,12-18,20H2,1H3,(H,31,34) QULJKIQETSQZKV-UHFFFAOYSA-N 50343786 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide::CHEMBL1774536 5-hydroxytryptamine receptor 1A Homo sapiens 299 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343786&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248256 131346722 CHEMBL1774536 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639891 FC(CCNC(=O)c1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H28Cl2FN3O/c29-25-6-3-7-26(27(25)30)34-14-12-33(13-15-34)18-22(31)10-11-32-28(35)20-8-9-24-21(17-20)16-19-4-1-2-5-23(19)24/h1-9,17,22H,10-16,18H2,(H,32,35) GTBCNDPVHSBZNR-UHFFFAOYSA-N 50343794 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-9H-fluorene-2-carboxamide::CHEMBL1774537 5-hydroxytryptamine receptor 1A Homo sapiens 6000 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343794&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248257 131346730 CHEMBL1774537 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639892 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1 InChI=1S/C24H28FN3O2S/c1-30-21-8-4-3-7-20(21)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-5-9-22(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) DSOWHOSHPUSGFM-UHFFFAOYSA-N 50343795 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774538 5-hydroxytryptamine receptor 1A Homo sapiens 139 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343795&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248258 131346731 CHEMBL1774538 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639893 FC(CCNC(=O)c1cc2ccccc2s1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3OS/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LIJLYDMKDQLIKS-UHFFFAOYSA-N 50343796 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774539 5-hydroxytryptamine receptor 1A Homo sapiens 2140 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343796&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248259 131346732 CHEMBL1774539 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639894 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H31FN4O3/c1-32-20-7-8-21-18(15-20)16-22(28-21)25(31)27-10-9-19(26)17-29-11-13-30(14-12-29)23-5-3-4-6-24(23)33-2/h3-8,15-16,19,28H,9-14,17H2,1-2H3,(H,27,31) XUBVWPDKERMCAP-UHFFFAOYSA-N 50343797 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774540 5-hydroxytryptamine receptor 1A Homo sapiens 1170 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343797&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248260 131346733 CHEMBL1774540 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639895 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(cc2)-c2ccccn2)CC1 InChI=1S/C27H31FN4O2/c1-34-26-8-3-2-7-25(26)32-18-16-31(17-19-32)20-23(28)13-15-30-27(33)22-11-9-21(10-12-22)24-6-4-5-14-29-24/h2-12,14,23H,13,15-20H2,1H3,(H,30,33) DXTFDOIEUMNMMV-UHFFFAOYSA-N 50343787 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-6-phenylnicotinamide::CHEMBL1774383 5-hydroxytryptamine receptor 1A Homo sapiens 71.6 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343787&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248158 131346723 CHEMBL1774383 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639896 FC(CCNC(=O)c1ccc(cc1)-c1ccccn1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C26H27Cl2FN4O/c27-22-4-3-6-24(25(22)28)33-16-14-32(15-17-33)18-21(29)11-13-31-26(34)20-9-7-19(8-10-20)23-5-1-2-12-30-23/h1-10,12,21H,11,13-18H2,(H,31,34) DUYVMDDLFWXUHZ-UHFFFAOYSA-N 50343788 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-6-phenylnicotinamide::CHEMBL1774384 5-hydroxytryptamine receptor 1A Homo sapiens 1080 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343788&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248159 131346724 CHEMBL1774384 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639897 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C24H28FN3O3/c1-30-22-9-5-3-7-20(22)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-4-8-21(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) VGOPWFPTLSPLJJ-UHFFFAOYSA-N 50343789 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzofuran-2-carboxamide::CHEMBL1774385 5-hydroxytryptamine receptor 1A Homo sapiens 134 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343789&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248208 131346725 CHEMBL1774385 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639898 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H30FN3O4/c1-31-20-7-8-22-18(15-20)16-24(33-22)25(30)27-10-9-19(26)17-28-11-13-29(14-12-28)21-5-3-4-6-23(21)32-2/h3-8,15-16,19H,9-14,17H2,1-2H3,(H,27,30) CSQTYZHHBNDDMS-UHFFFAOYSA-N 50343790 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774532 5-hydroxytryptamine receptor 1A Homo sapiens 600 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343790&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248210 131346726 CHEMBL1774532 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639899 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C24H29FN4O2/c1-31-23-9-5-4-8-22(23)29-14-12-28(13-15-29)17-19(25)10-11-26-24(30)21-16-18-6-2-3-7-20(18)27-21/h2-9,16,19,27H,10-15,17H2,1H3,(H,26,30) JLMZACVBNICYMZ-UHFFFAOYSA-N 50343792 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide::CHEMBL1774534 5-hydroxytryptamine receptor 1A Homo sapiens 1430 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343792&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248212 131346728 CHEMBL1774534 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639900 FC(CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H25Cl2FN4O/c24-18-5-3-7-21(22(18)25)30-12-10-29(11-13-30)15-17(26)8-9-27-23(31)20-14-16-4-1-2-6-19(16)28-20/h1-7,14,17,28H,8-13,15H2,(H,27,31) VIHBCLOGDPFGGP-UHFFFAOYSA-N 50343793 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-1H-indole-2-carboxamide::CHEMBL1774535 5-hydroxytryptamine receptor 1A Homo sapiens 2140 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343793&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248213 131346729 CHEMBL1774535 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639901 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1 InChI=1S/C24H28FN3O2S/c1-30-21-8-4-3-7-20(21)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-5-9-22(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) DSOWHOSHPUSGFM-UHFFFAOYSA-N 50343795 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774538 5-hydroxytryptamine receptor 1A Homo sapiens 440 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343795&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 53248258 131346731 CHEMBL1774538 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 50639902 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(cc2)-c2ccccn2)CC1 InChI=1S/C27H31FN4O2/c1-34-26-8-3-2-7-25(26)32-18-16-31(17-19-32)20-23(28)13-15-30-27(33)22-11-9-21(10-12-22)24-6-4-5-14-29-24/h2-12,14,23H,13,15-20H2,1H3,(H,30,33) DXTFDOIEUMNMMV-UHFFFAOYSA-N 50343787 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-6-phenylnicotinamide::CHEMBL1774383 5-hydroxytryptamine receptor 2A Homo sapiens 2060 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343787&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248158 131346723 CHEMBL1774383 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639903 FC(CCNC(=O)c1ccc(cc1)-c1ccccn1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C26H27Cl2FN4O/c27-22-4-3-6-24(25(22)28)33-16-14-32(15-17-33)18-21(29)11-13-31-26(34)20-9-7-19(8-10-20)23-5-1-2-12-30-23/h1-10,12,21H,11,13-18H2,(H,31,34) DUYVMDDLFWXUHZ-UHFFFAOYSA-N 50343788 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-6-phenylnicotinamide::CHEMBL1774384 5-hydroxytryptamine receptor 2A Homo sapiens 98 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343788&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248159 131346724 CHEMBL1774384 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639904 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1 InChI=1S/C24H28FN3O3/c1-30-22-9-5-3-7-20(22)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-4-8-21(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) VGOPWFPTLSPLJJ-UHFFFAOYSA-N 50343789 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzofuran-2-carboxamide::CHEMBL1774385 5-hydroxytryptamine receptor 2A Homo sapiens 4800 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343789&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248208 131346725 CHEMBL1774385 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639905 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H30FN3O4/c1-31-20-7-8-22-18(15-20)16-24(33-22)25(30)27-10-9-19(26)17-28-11-13-29(14-12-28)21-5-3-4-6-23(21)32-2/h3-8,15-16,19H,9-14,17H2,1-2H3,(H,27,30) CSQTYZHHBNDDMS-UHFFFAOYSA-N 50343790 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774532 5-hydroxytryptamine receptor 2A Homo sapiens 3000 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343790&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248210 131346726 CHEMBL1774532 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639906 COc1ccc2oc(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H26Cl2FN3O3/c1-32-18-5-6-21-16(13-18)14-22(33-21)24(31)28-8-7-17(27)15-29-9-11-30(12-10-29)20-4-2-3-19(25)23(20)26/h2-6,13-14,17H,7-12,15H2,1H3,(H,28,31) TXDNMFSXILPGFK-UHFFFAOYSA-N 50343791 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxybenzofuran-2-carboxamide::CHEMBL1774533 5-hydroxytryptamine receptor 2A Homo sapiens 274 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343791&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248211 131346727 CHEMBL1774533 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639907 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1 InChI=1S/C24H29FN4O2/c1-31-23-9-5-4-8-22(23)29-14-12-28(13-15-29)17-19(25)10-11-26-24(30)21-16-18-6-2-3-7-20(18)27-21/h2-9,16,19,27H,10-15,17H2,1H3,(H,26,30) JLMZACVBNICYMZ-UHFFFAOYSA-N 50343792 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide::CHEMBL1774534 5-hydroxytryptamine receptor 2A Homo sapiens 3240 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343792&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248212 131346728 CHEMBL1774534 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639908 FC(CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H25Cl2FN4O/c24-18-5-3-7-21(22(18)25)30-12-10-29(11-13-30)15-17(26)8-9-27-23(31)20-14-16-4-1-2-6-19(16)28-20/h1-7,14,17,28H,8-13,15H2,(H,27,31) VIHBCLOGDPFGGP-UHFFFAOYSA-N 50343793 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-1H-indole-2-carboxamide::CHEMBL1774535 5-hydroxytryptamine receptor 2A Homo sapiens 212 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343793&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248213 131346729 CHEMBL1774535 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639909 FC(CCNC(=O)c1ccc-2c(Cc3ccccc-23)c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C28H28Cl2FN3O/c29-25-6-3-7-26(27(25)30)34-14-12-33(13-15-34)18-22(31)10-11-32-28(35)20-8-9-24-21(17-20)16-19-4-1-2-5-23(19)24/h1-9,17,22H,10-16,18H2,(H,32,35) GTBCNDPVHSBZNR-UHFFFAOYSA-N 50343794 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-9H-fluorene-2-carboxamide::CHEMBL1774537 5-hydroxytryptamine receptor 2A Homo sapiens 4800 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343794&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248257 131346730 CHEMBL1774537 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639910 COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1 InChI=1S/C24H28FN3O2S/c1-30-21-8-4-3-7-20(21)28-14-12-27(13-15-28)17-19(25)10-11-26-24(29)23-16-18-6-2-5-9-22(18)31-23/h2-9,16,19H,10-15,17H2,1H3,(H,26,29) DSOWHOSHPUSGFM-UHFFFAOYSA-N 50343795 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774538 5-hydroxytryptamine receptor 2A Homo sapiens 3030 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343795&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248258 131346731 CHEMBL1774538 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639911 FC(CCNC(=O)c1cc2ccccc2s1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3OS/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LIJLYDMKDQLIKS-UHFFFAOYSA-N 50343796 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzo[b]thiophene-2-carboxamide::CHEMBL1774539 5-hydroxytryptamine receptor 2A Homo sapiens 3290 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343796&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248259 131346732 CHEMBL1774539 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639912 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1ccccc1OC InChI=1S/C25H31FN4O3/c1-32-20-7-8-21-18(15-20)16-22(28-21)25(31)27-10-9-19(26)17-29-11-13-30(14-12-29)23-5-3-4-6-24(23)33-2/h3-8,15-16,19,28H,9-14,17H2,1-2H3,(H,27,31) XUBVWPDKERMCAP-UHFFFAOYSA-N 50343797 N-(3-Fluoro-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774540 5-hydroxytryptamine receptor 2A Homo sapiens 3540 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343797&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248260 131346733 CHEMBL1774540 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639913 COc1ccc2[nH]c(cc2c1)C(=O)NCCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C24H27Cl2FN4O2/c1-33-18-5-6-20-16(13-18)14-21(29-20)24(32)28-8-7-17(27)15-30-9-11-31(12-10-30)22-4-2-3-19(25)23(22)26/h2-6,13-14,17,29H,7-12,15H2,1H3,(H,28,32) WBGWXELVCBHOMZ-UHFFFAOYSA-N 50343798 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-5-methoxy-1H-indole-2-carboxamide::CHEMBL1774541 5-hydroxytryptamine receptor 2A Homo sapiens 272 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343798&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248261 131346734 CHEMBL1774541 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639914 FC(CCNC(=O)c1ccc2ccccc2c1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C25H26Cl2FN3O/c26-22-6-3-7-23(24(22)27)31-14-12-30(13-15-31)17-21(28)10-11-29-25(32)20-9-8-18-4-1-2-5-19(18)16-20/h1-9,16,21H,10-15,17H2,(H,29,32) CNIUTIHLBNEOKA-UHFFFAOYSA-N 50343799 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-2-naphthamide::CHEMBL1774542 5-hydroxytryptamine receptor 2A Homo sapiens 1910 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343799&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248298 131346735 CHEMBL1774542 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639915 CN(CCC(F)CN1CCN(CC1)c1cccc(Cl)c1Cl)Cc1ccc-2c(Cc3ccccc-23)c1 InChI=1S/C29H32Cl2FN3/c1-33(19-21-9-10-26-23(17-21)18-22-5-2-3-6-25(22)26)12-11-24(32)20-34-13-15-35(16-14-34)28-8-4-7-27(30)29(28)31/h2-10,17,24H,11-16,18-20H2,1H3 KROSHEKWTTXFGB-UHFFFAOYSA-N 50343809 N-((9H-Fluoren-2-yl)methyl)-4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-3-fluoro-N-methylbutan-1-amine::CHEMBL1773087 5-hydroxytryptamine receptor 2A Homo sapiens 2580 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343809&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 53248395 131346745 CHEMBL1773087 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 50639916 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 D(2) dopamine receptor Homo sapiens 0.03 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639917 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 D(3) dopamine receptor Homo sapiens 0.04 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639918 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 D(2) dopamine receptor Homo sapiens 9163 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 9BSB,9BS9,8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 50639919 FC(CCNC(=O)c1cc2ccccc2o1)CN1CCN(CC1)c1cccc(Cl)c1Cl InChI=1S/C23H24Cl2FN3O2/c24-18-5-3-6-19(22(18)25)29-12-10-28(11-13-29)15-17(26)8-9-27-23(30)21-14-16-4-1-2-7-20(16)31-21/h1-7,14,17H,8-13,15H2,(H,27,30) LRBUVURCWWAQQT-UHFFFAOYSA-N 50343785 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)-3-fluorobutyl)-benzofuran-2-carboxamide::CHEMBL1774386 D(3) dopamine receptor Homo sapiens 5.4 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50343785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50343785&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 53248209 131346721 CHEMBL1774386 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 50639920 O[C@H](CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl |r| InChI=1S/C23H26Cl2N4O2/c24-18-5-3-7-21(22(18)25)29-12-10-28(11-13-29)15-17(30)8-9-26-23(31)20-14-16-4-1-2-6-19(16)27-20/h1-7,14,17,27,30H,8-13,15H2,(H,26,31) NABHHUMHJIHHIX-UHFFFAOYSA-N 50342720 (R)-N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)-1H-indole-2-carboxamide::CHEMBL1627306 D(3) dopamine receptor Homo sapiens 495 ChEMBL 10.1021/jm200288r 10.7270/Q25M661K 21495689 Banala, AK; Levy, BA; Khatri, SS; Furman, CA; Roof, RA; Mishra, Y; Griffin, SA; Sibley, DR; Luedtke, RR; Newman, AH 5/19/2011 12/4/2011 National Institute On Drug Abuse-Intramural Research Program http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50342720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50342720&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 42626318 131345656 CHEMBL1627306 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8